FDAHealthJuly 16, 2026
Fresenius Kabi USA, LLC — Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047
⚠️ Presence of Particulate Matter: Hair was found in products
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- July 16, 2026
Nationwide within in the USA
What's affected?
- Product
- Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
- Brand
- NAROPIN
- UPC
- 0363323286033
- Lot code
- 6133436
Additional details
Lot #: 6133436, Exp. Date 10/2028
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 92,600 vials.
Get Health recall alerts
Delivered to your inbox. Free. No account required.